These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10637333)

  • 1. Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.
    Wittekindt NE; Hörtnagel K; Geltinger C; Polack A
    Nucleic Acids Res; 2000 Feb; 28(3):800-8. PubMed ID: 10637333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
    Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
    J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers.
    Geltinger C; Hörtnagel K; Polack A
    Gene Expr; 1996; 6(2):113-27. PubMed ID: 8979089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.
    Polack A; Feederle R; Klobeck G; Hörtnagel K
    EMBO J; 1993 Oct; 12(10):3913-20. PubMed ID: 8404859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.
    Liu H; Zheng H; Duan Z; Hu D; Li M; Liu S; Li Z; Deng X; Wang Z; Tang M; Shi Y; Yi W; Cao Y
    Mol Cancer; 2009 Oct; 8():92. PubMed ID: 19860880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of immunoglobulin kappa elements in c-myc activation.
    Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
    Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
    Hu HM; Kanda K; Zhang L; Boxer LM
    Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation in Burkitt's lymphoma cells.
    Hörtnagel K; Polack A; Mautner J; Feederle R; Bornkamm GW
    Curr Top Microbiol Immunol; 1995; 194():415-22. PubMed ID: 7895517
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
    Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
    Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo.
    Mautner J; Behrends U; Hörtnagel K; Brielmeier M; Hammerschmidt W; Strobl L; Bornkamm GW; Polack A
    Oncogene; 1996 Mar; 12(6):1299-307. PubMed ID: 8649832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
    Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
    Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
    Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
    Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Myc and Sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter.
    Park NH; Guo W; Kim HR; Kang MK; Park NH
    Int J Oncol; 2001 Oct; 19(4):755-61. PubMed ID: 11562751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an enhancer and an alternative promoter in the first intron of the alpha-fetoprotein gene.
    Scohy S; Gabant P; Szpirer C; Szpirer J
    Nucleic Acids Res; 2000 Oct; 28(19):3743-51. PubMed ID: 11000266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L; Groudine M
    Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-myc oncogene expression in neuroblastoma is driven by Sp1 and Sp3.
    Tuthill MC; Wada RK; Arimoto JM; Sugino CN; Kanemaru KK; Takeuchi KK; Sidell N
    Mol Genet Metab; 2003; 80(1-2):272-80. PubMed ID: 14567977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.